VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CALC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CALCCalciMedica, Inc.
$0.99$15M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCALCQuarterly Financials

CalciMedica, Inc. (CALC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

CalciMedica, Inc. (CALC) quarterly income statement — complete revenue, gross profit & net income history

CALC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold7K000014K00000000013K0000
COGS % of Revenue--------------------
Gross Profit-7K0000-14K000000000-13K0000
Gross Margin %--------------------
Gross Profit Growth %-100%---------100%--------
Operating Expenses5.6M4.38M5.62M6.62M6.5M6.16M5.74M6.53M5.77M4.32M4.83M6.58M22.34M3.1M3.29M3.58M4.21M4.08M8.02M7.74M
OpEx % of Revenue--------------------
Selling, General & Admin2.12M1.28M1.77M2.57M2.27M2.33M2.19M2.37M2.82M1.54M2.06M2.77M3.15M1.18M2.04M1.32M1.29M1.32M4M3.58M
SG&A % of Revenue--------------------
Research & Development3.48M3.11M3.85M4.05M4.22M3.83M3.55M4.16M2.94M2.78M2.77M3.81M6.49M1.92M1.24M2.26M2.92M2.75M4.02M4.17M
R&D % of Revenue--------------------
Other Operating Expenses0000000000001000K0000000
Operating Income-5.61M-4.38M-5.62M-6.62M-6.5M-6.17M-5.74M-6.53M-5.77M-4.32M-4.83M-6.58M-22.34M-3.1M-3.29M-3.59M-4.21M-4.08M-8.02M-7.74M
Operating Margin %--------------------
Operating Income Growth %13.64%28.95%2.06%-1.41%-12.66%-42.9%-18.68%0.82%74.19%-39.1%-46.99%-83.42%-430.52%23.86%58.99%53.64%63.34%55.55%-17.53%-28.16%
EBITDA-5.6M-4.38M-5.61M-6.61M-6.48M-6.16M-5.72M-6.51M-5.75M-4.3M-4.82M-6.57M-22.33M-3.09M-3.27M-3.58M-4.2M-4.07M-7.88M-7.61M
EBITDA Margin %--------------------
EBITDA Growth %13.55%28.87%2.01%-1.41%-12.69%-43.21%-18.67%0.82%74.24%-39.07%-47.21%-83.7%-431.85%23.95%58.44%53.02%63.08%55.14%-17.19%-28.04%
D&A (Non-Cash Add-back)7K5K12K14K15K14K15K14K15K19K12K14K13K13K13K13K13K12K136K129K
EBIT-5.61M-10.44M-7.48M-5.63M-4.59M-4.26M-5.74M-3.95M130K-4.32M-4.83M-6.58M-6.14M-3.1M-3.29M-3.03M-4.21M-4.08M-8.02M-7.74M
Net Interest Income-213K-174K-186K-104K-245K00000000309K171K60K35K26K28K33K
Interest Income106K151K140K220K202K00000000309K171K60K35K26K28K33K
Interest Expense319K325K326K324K447K000000000000000
Other Income/Expense10.59M-6.38M-2.19M665K1.46M1.91M118K2.58M5.9M173K214K279K3.05M4.52M707K559K581K-328K28K33K
Pretax Income4.98M-10.76M-7.8M-5.96M-5.04M-4.26M-5.62M-3.95M130K-4.15M-4.62M-6.3M-19.29M1.42M-2.58M-3.03M-3.63M-4.41M-7.99M-7.71M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income4.98M-10.76M-7.8M-5.96M-5.04M-4.26M-5.62M-3.95M130K-4.15M-4.62M-6.3M-19.29M1.42M-2.58M-3.03M-3.63M-4.41M-7.99M-7.71M
Net Margin %--------------------
Net Income Growth %198.69%-152.7%-38.91%-50.63%-3978.46%-2.7%-21.63%37.28%100.67%-392.59%-78.96%-108.05%-431.35%132.16%67.69%60.69%68.29%51.86%-69.4%-31.33%
Net Income (Continuing)4.98M-10.76M-7.8M-5.96M-5.04M-4.26M-5.62M-3.95M130K-4.15M-4.62M-6.3M-19.29M1.42M-2.58M-3.03M-3.63M-4.41M-7.99M-7.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.30-0.70-0.52-0.40-0.36-0.33-0.50-0.360.01-0.72-0.81-1.11-23.52-4.79-6.39-5.37-6.61-5.69-5.25-5.10
EPS Growth %183.33%-112.12%-4%-11.11%-2890.7%54.17%38.27%67.57%100.05%84.97%87.32%79.33%-255.82%15.82%-21.71%-5.29%13.37%6.87%77.59%-18.88%
EPS (Basic)0.31-0.69-0.52-0.40-0.36-0.33-0.50-0.360.01-0.72-0.81-1.11-23.52-4.79-6.39-5.37-6.61-5.69-5.25-5.10
Diluted Shares Outstanding15.01M15.01B15M15M14.12M12.76M11.13M11.13M10.05M5.74M5.67M5.66M820K1.54M1.53M1.53M1.53M1.52M1.52M1.51M
Basic Shares Outstanding15.01M15.01B15M15M14.12M12.76M11.13M11.13M9.75M5.74M5.67M5.66M820K1.54M1.53M1.53M1.53M1.52M1.52M1.51M
Dividend Payout Ratio--------------------